Cullen Investment Group, Ltd. Abb Vie Inc. Transaction History
Cullen Investment Group, Ltd.
- $627 Billion
- Q2 2024
A detailed history of Cullen Investment Group, Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 13,296 shares of ABBV stock, worth $2.48 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
13,296
Previous 13,598
2.22%
Holding current value
$2.48 Million
Previous $2.46 Billion
7.18%
% of portfolio
0.36%
Previous 0.39%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
3,652Shares Held
1.23BCall Options Held
15.5MPut Options Held
11.5M-
Vanguard Group Inc Valley Forge, PA170MShares$31.8 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$26.7 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$14.6 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$9.57 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.98 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $330B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...